Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Principles for adjuvant and neoadjuvant chemotherapy]

M Fukuoka1, R Tsuchiya

  • 1Dept. of Pulmonary Medicine, Osaka City General Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 1, 1994
PubMed
Summary

Early systemic therapy, including adjuvant and neoadjuvant chemotherapy, aims to eliminate micrometastatic disease and improve survival. Increased chemotherapy dose intensity shows promise for better disease-free and overall survival in breast cancer patients.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Identification of thymidylate synthase as a potential therapeutic target for lung cancer.

British journal of cancer·2025
Same author

Biomechanical comparison of titanium alloy additively manufactured and conventionally manufactured plate-screw constructs.

New Zealand veterinary journal·2023
Same author

Migratory bone lesions in lymphoma.

QJM : monthly journal of the Association of Physicians·2022
Same author

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study.

Lung cancer (Amsterdam, Netherlands)·2020
Same author

The dynamics of granular flow from a silo with two symmetric openings.

Proceedings. Mathematical, physical, and engineering sciences·2019
Same author

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Oncology
  • Clinical Trials
  • Cancer Treatment